IDEXX LABORATORIES INC /DE Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost
IDEXX LABORATORIES INC /DE (IDXX) had Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost of $284.43 million as of 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Notes › Investments › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost · last filed 2018-02-16
- 2017-12-31: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost $284.43M.
- 2017-09-30: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost $284.98M.
- 2017-06-30: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost $256.82M.
- 2017-03-31: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost $239.96M.
| Period end | Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost |
|---|---|
| 2017-12-31 | $284.43M 10-K · filed 2018-02-16 |
| 2017-09-30 | $284.98M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $256.82M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $239.96M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $237.00M 10-K · filed 2017-02-17 |
| 2016-09-30 | $241.29M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $228.88M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $217.57M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $213.80M 10-K · filed 2016-02-17 |
| 2015-09-30 | $208.50M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $181.01M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $139.28M 10-Q · filed 2015-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |